EXOZYMES INC.

EXOZ ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K Feb 5, 2026 8-K
424B2 Jan 26, 2026 424B2
EFFECT Jan 23, 2026
CORRESP Jan 22, 2026
S-3 Jan 16, 2026 S-3
S-8 Dec 16, 2025 S-8
DRS Dec 15, 2025
8-K Dec 12, 2025 8-K
8-K Nov 13, 2025 8-K
10-Q Nov 13, 2025 10-Q
8-K Oct 3, 2025 8-K
10-Q Aug 12, 2025 10-Q
8-K Jul 28, 2025 8-K
424B3 Jul 8, 2025 424B3
8-K Jul 8, 2025 8-K
4 Jul 2, 2025
8-K Jun 26, 2025 8-K
DEFR14A Jun 23, 2025 DEFR14A
DEF 14A Jun 20, 2025 DEF 14A
8-K Jun 20, 2025 8-K
4 Jun 20, 2025 4
4 Jun 17, 2025 4
4 Jun 17, 2025 4
4 Jun 17, 2025 4
10-Q May 12, 2025 10-Q
← Newer Page 2 of 5 · 115 filings Older →